Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0877220000040010027
Journal of Korean Epilepsy Society
2000 Volume.4 No. 1 p.27 ~ p.29
Efficacy of Topiramate in West Syndrome
Lee In-Kyu

Kim Sung-Koo
Lee Ran
Kwon Young-Se
Lee Jong-Hwa
Chae Jong-Hee
Kim Ki-Joong
Hwang Yong-Seung
Abstract
Purpose: The treatment of West syndrome is difficult since current antiepileptic drugs are rarely effective. The objective of this study is to evaluate the clinical efficacy of topiramate as add-on therapy in the refractory West Syndrome.
Methods: Nineteen children with refractory infantile spasms were included in this study. Topiramate was given as an initial dose of 25 mg per day in addition to the current antiepileptic drug (s). Dosage was increased by 25 mg every week until spasms were controlled, the maximal tolerable dose was reached, or the maximal dose of 25 mg/kg/day was achieved.

Results: Five (26.3%) subjects became seizure free and 7 (36.8%) achieved seizure frequency reduction more than 50%. No significant side effect of topiramate was noted.

Conclusion: Topiramate could be a promising therapy in the treatment of refractory West syndrome.
KEYWORD
Topiramate, West syndrome, Topiramate
FullTexts / Linksout information
 
Listed journal information
KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø